Many elderly patients with metastatic renal cell carcinoma benefit from targeted therapies

(University of Pennsylvania School of Medicine) Many elderly patients with metastatic renal cell carcinoma (RCC) -- who are often underrepresented in clinical trials to treat the kidney cancer -- are seeing overall survival benefits from treatment with targeted therapies, according to a new study published in JAMA Network Open.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news